CMTA invests $165,000 in University of Iowa research led by Michael Shy, MD, and Robert Piper, PhD, to determine the right time to begin treatment for CMT1A and CMT1E.
When Should Treatment Begin in CMT1A and CMT1E?
What if the timing of treatment could change everything? CMTA is funding a new study to find the optimal window for treating CMT1A and CMT1E; and to discover how to tell if it's working.
